Micropenis in hypogonadotropic hypogonadism: Response of the penile androgen receptor to testosterone treatment

Douglas N. Tietjen, Greg Y. Uramoto, Donald J. Tindall, Douglas A. Husmann

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: We determine whether testosterone therapy alters penile androgen receptor expression within the hypogonadotropic hypogonadal (HPG) micropenis. Materials and Methods: In protocol 1 a strain of mice with micropenis due to congenital HPG and wild type litter mates were divided into testosterone treated and untreated groups. Treatment was initiated on day 15 of life. On day 90 of life (day 75 of treatment) the mice were sacrificed, and the penises were removed and weighed. In protocol 2 microphallic mice treated with testosterone were sacrificed on days 0, 6, 30, 60 and 75 after the initiation of treatment. Untreated HPG and wild type litter mates served as controls. At autopsy the penis was removed and weighed, and androgen receptor content was determined by Western immunoblotting. Results: Testosterone treatment resulted in 6-fold up regulation in HPG penile androgen receptor, approximately 1.4-fold higher than in the normal wild type pubescent penis. Testosterone induced and wild type pubescent penile androgen receptor up regulation was maintained for approximately 75 and 60 days, respectively. Despite improved HPG penile androgen receptor expression penile growth did not become normal. Average total penile weight plus or minus standard deviation was 7.2 ± 3.5 mg. in untreated HPG mice. Testosterone significantly improved average HPG penile weight to 23.5 ± 1.8 mg. (p <0.001). However, the testosterone treated micropenis failed to reach average normal penile size (38.6 ± 2.6 mg., p <0.001). Conclusions: Testosterone increases the concentration and duration of penile androgen receptor expression within the HPG micropenis. Despite this improvement microphallic HPG penile growth does not become normal.

Original languageEnglish (US)
Pages (from-to)1054-1057
Number of pages4
JournalJournal of Urology
Volume160
Issue number3 II
DOIs
StatePublished - 1998

Fingerprint

Hypogonadism
Androgen Receptors
Testosterone
Penis
Up-Regulation
Weights and Measures
Penis agenesis
Growth
Autopsy
Western Blotting

Keywords

  • Abnormalities
  • Hypogonadism
  • Penis
  • Receptors, androgen

ASJC Scopus subject areas

  • Urology

Cite this

Micropenis in hypogonadotropic hypogonadism : Response of the penile androgen receptor to testosterone treatment. / Tietjen, Douglas N.; Uramoto, Greg Y.; Tindall, Donald J.; Husmann, Douglas A.

In: Journal of Urology, Vol. 160, No. 3 II, 1998, p. 1054-1057.

Research output: Contribution to journalArticle

Tietjen, Douglas N. ; Uramoto, Greg Y. ; Tindall, Donald J. ; Husmann, Douglas A. / Micropenis in hypogonadotropic hypogonadism : Response of the penile androgen receptor to testosterone treatment. In: Journal of Urology. 1998 ; Vol. 160, No. 3 II. pp. 1054-1057.
@article{b24a0d319acf4f79bb2b33c48f587e78,
title = "Micropenis in hypogonadotropic hypogonadism: Response of the penile androgen receptor to testosterone treatment",
abstract = "Purpose: We determine whether testosterone therapy alters penile androgen receptor expression within the hypogonadotropic hypogonadal (HPG) micropenis. Materials and Methods: In protocol 1 a strain of mice with micropenis due to congenital HPG and wild type litter mates were divided into testosterone treated and untreated groups. Treatment was initiated on day 15 of life. On day 90 of life (day 75 of treatment) the mice were sacrificed, and the penises were removed and weighed. In protocol 2 microphallic mice treated with testosterone were sacrificed on days 0, 6, 30, 60 and 75 after the initiation of treatment. Untreated HPG and wild type litter mates served as controls. At autopsy the penis was removed and weighed, and androgen receptor content was determined by Western immunoblotting. Results: Testosterone treatment resulted in 6-fold up regulation in HPG penile androgen receptor, approximately 1.4-fold higher than in the normal wild type pubescent penis. Testosterone induced and wild type pubescent penile androgen receptor up regulation was maintained for approximately 75 and 60 days, respectively. Despite improved HPG penile androgen receptor expression penile growth did not become normal. Average total penile weight plus or minus standard deviation was 7.2 ± 3.5 mg. in untreated HPG mice. Testosterone significantly improved average HPG penile weight to 23.5 ± 1.8 mg. (p <0.001). However, the testosterone treated micropenis failed to reach average normal penile size (38.6 ± 2.6 mg., p <0.001). Conclusions: Testosterone increases the concentration and duration of penile androgen receptor expression within the HPG micropenis. Despite this improvement microphallic HPG penile growth does not become normal.",
keywords = "Abnormalities, Hypogonadism, Penis, Receptors, androgen",
author = "Tietjen, {Douglas N.} and Uramoto, {Greg Y.} and Tindall, {Donald J.} and Husmann, {Douglas A.}",
year = "1998",
doi = "10.1016/S0022-5347(01)62696-X",
language = "English (US)",
volume = "160",
pages = "1054--1057",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3 II",

}

TY - JOUR

T1 - Micropenis in hypogonadotropic hypogonadism

T2 - Response of the penile androgen receptor to testosterone treatment

AU - Tietjen, Douglas N.

AU - Uramoto, Greg Y.

AU - Tindall, Donald J.

AU - Husmann, Douglas A.

PY - 1998

Y1 - 1998

N2 - Purpose: We determine whether testosterone therapy alters penile androgen receptor expression within the hypogonadotropic hypogonadal (HPG) micropenis. Materials and Methods: In protocol 1 a strain of mice with micropenis due to congenital HPG and wild type litter mates were divided into testosterone treated and untreated groups. Treatment was initiated on day 15 of life. On day 90 of life (day 75 of treatment) the mice were sacrificed, and the penises were removed and weighed. In protocol 2 microphallic mice treated with testosterone were sacrificed on days 0, 6, 30, 60 and 75 after the initiation of treatment. Untreated HPG and wild type litter mates served as controls. At autopsy the penis was removed and weighed, and androgen receptor content was determined by Western immunoblotting. Results: Testosterone treatment resulted in 6-fold up regulation in HPG penile androgen receptor, approximately 1.4-fold higher than in the normal wild type pubescent penis. Testosterone induced and wild type pubescent penile androgen receptor up regulation was maintained for approximately 75 and 60 days, respectively. Despite improved HPG penile androgen receptor expression penile growth did not become normal. Average total penile weight plus or minus standard deviation was 7.2 ± 3.5 mg. in untreated HPG mice. Testosterone significantly improved average HPG penile weight to 23.5 ± 1.8 mg. (p <0.001). However, the testosterone treated micropenis failed to reach average normal penile size (38.6 ± 2.6 mg., p <0.001). Conclusions: Testosterone increases the concentration and duration of penile androgen receptor expression within the HPG micropenis. Despite this improvement microphallic HPG penile growth does not become normal.

AB - Purpose: We determine whether testosterone therapy alters penile androgen receptor expression within the hypogonadotropic hypogonadal (HPG) micropenis. Materials and Methods: In protocol 1 a strain of mice with micropenis due to congenital HPG and wild type litter mates were divided into testosterone treated and untreated groups. Treatment was initiated on day 15 of life. On day 90 of life (day 75 of treatment) the mice were sacrificed, and the penises were removed and weighed. In protocol 2 microphallic mice treated with testosterone were sacrificed on days 0, 6, 30, 60 and 75 after the initiation of treatment. Untreated HPG and wild type litter mates served as controls. At autopsy the penis was removed and weighed, and androgen receptor content was determined by Western immunoblotting. Results: Testosterone treatment resulted in 6-fold up regulation in HPG penile androgen receptor, approximately 1.4-fold higher than in the normal wild type pubescent penis. Testosterone induced and wild type pubescent penile androgen receptor up regulation was maintained for approximately 75 and 60 days, respectively. Despite improved HPG penile androgen receptor expression penile growth did not become normal. Average total penile weight plus or minus standard deviation was 7.2 ± 3.5 mg. in untreated HPG mice. Testosterone significantly improved average HPG penile weight to 23.5 ± 1.8 mg. (p <0.001). However, the testosterone treated micropenis failed to reach average normal penile size (38.6 ± 2.6 mg., p <0.001). Conclusions: Testosterone increases the concentration and duration of penile androgen receptor expression within the HPG micropenis. Despite this improvement microphallic HPG penile growth does not become normal.

KW - Abnormalities

KW - Hypogonadism

KW - Penis

KW - Receptors, androgen

UR - http://www.scopus.com/inward/record.url?scp=0032323309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032323309&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)62696-X

DO - 10.1016/S0022-5347(01)62696-X

M3 - Article

C2 - 9719275

AN - SCOPUS:0032323309

VL - 160

SP - 1054

EP - 1057

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3 II

ER -